Matches in Nanopublications for { ?s ?p "[We evaluated the expression of tissue factor (TF) in ovarian cancer (EOC) and the potential of hI-con1, an antibody-like molecule targeting TF, as a novel form of therapy against chemotherapy-resistant ovarian disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- assertion description "[We evaluated the expression of tissue factor (TF) in ovarian cancer (EOC) and the potential of hI-con1, an antibody-like molecule targeting TF, as a novel form of therapy against chemotherapy-resistant ovarian disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP390867.RAO4jiLNm5HYMrYuOXAXxYVSsmXJPoximOyUUW_9SHgZA130_assertion description "[We evaluated the expression of tissue factor (TF) in ovarian cancer (EOC) and the potential of hI-con1, an antibody-like molecule targeting TF, as a novel form of therapy against chemotherapy-resistant ovarian disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP390867.RAO4jiLNm5HYMrYuOXAXxYVSsmXJPoximOyUUW_9SHgZA130_provenance.
- NP906932.RAFtKXngkanIcAyJhhSwn29OEShzN_n3Lg_fEQQzrKX78130_assertion description "[We evaluated the expression of tissue factor (TF) in ovarian cancer (EOC) and the potential of hI-con1, an antibody-like molecule targeting TF, as a novel form of therapy against chemotherapy-resistant ovarian disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP906932.RAFtKXngkanIcAyJhhSwn29OEShzN_n3Lg_fEQQzrKX78130_provenance.